The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Spiriva 18 microgram inhalation powder, hard capsule

18 microgram(s) Inhalation Powder, Capsule

Primecrown 2010 LimitedPPA1633/020/001

Main Information

Trade NameSpiriva 18 microgram inhalation powder, hard capsule
Active SubstancesTiotropium bromide
Strength18 microgram(s)
Dosage FormInhalation Powder, Capsule
Licence HolderPrimecrown 2010 Limited
Licence NumberPPA1633/020/001

Group Information

ATC CodeR03BB Anticholinergics
R03BB04 tiotropium bromide

Status

Authorised/WithdrawnAuthorised
Licence Issued17/08/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back